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Background: A 2003 survey suggested the number of noncommercial trials in the UK was declining. Formation of
the NIHR in 2006 and increased research spending by the Department of Health may have increased the number
of noncommercial trials but no data are available.
Methods: Available data on UK noncommercial trials (were obtained from the two relevant registries: ISRCTN
register for the UK, and US ClinicalTrials.gov. Data on each trial were sorted by start year, and compared with the:
2003 survey, and UKCRN portfolio database from 2007.
Results: The number of UK noncommercial trials registered rose from 25 in 1990 to 188 in 1999, peaked at 533 in
2003, and fell back to 334 in 2009. Total trials registered was similar to but slightly above those in the 2003 survey
up to 1998, then rose sharply to 2002 before falling to 2007. From 2007 to 2009 the number registered to start
each year was similar to but slightly above the UKCRN database. Less than 10% of UK noncommercial trials
registered with ClinGov for most years before 2005, but this rose to 35% by 2009.
Conclusions: For the periods of overlap, trial registration data provide fairly similar totals to other sources on the
number of noncommercial trials starting each year. The rise and fall in the number of trials registered between
1999 and 2007 was due to those registered in the ISRCTN database as funded by NHS Trusts. After 2007, the
number of trials registered as funded by NHS Trusts has fallen in the ISRCTN register but these trials may have
migrated to the US ClinGov register. The total number of noncommercial trial starts, excluding those funded by
NHS Trusts, has been upward since around 2002. By 2009 the two main funders were NIHR and charities. Feasibility
of using registration data to monitor the number of noncommercial trials has been demonstrated but is
complicated by the use of two registers and difficulties in accessing the data. We recommend an annual report on
the number of noncommercial trials registering each year.
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Concerns have been raised about a reduced number of
clinical trials conducted in the UK, both commercial and
noncommercial [1]. However, the Medicines and Health-
care Products Regulatory Agency – which authorises
trials of medicines – has put the number of trials at a
steady 1,200 per year from 2002 to 2009, split roughly
into 75% commercial and 25% noncommercial [2,3].* Correspondence: raftery@soton.ac.uk
1University of Southampton, Southampton, UK
Full list of author information is available at the end of the article
© 2012 Raftery et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orChalmers and colleagues sounded an alarm in 2003 that
the number of noncommercial trials in the UK was declin-
ing, based on a survey of the main funders [4]. This survey
showed around 150 trials starting in 1997, falling to 40 in
2002. From 2007 the UK Clinical Research Network
(UKCRN) portfolio database on trials being carried
out in the National Health Service (NHS) put the
number of noncommercial trials starting each year in
the UK at around 300 [5].
Registration of clinical trials has become increasingly
common due to statutory requirements in the USA [6]
and for publication in medical journals [7]. The revisedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.trialsjournal.com/content/13/1/1402008 Declaration of Helsinki states that ‘Every clinical
trial must be registered in a publicly accessible database
before recruitment of the first subject’ [6].
Although registration is not compulsory in the UK,
clinical governance arrangements from 2004 have
required registration [8].
UK triallists have registered with either the US Clinical
Trials Government Register (ClinGov) or the International
Standard Randomised Controlled Trials Number register
(ISRCTN). ClinGov, run by the US National Library of
Medicine, was the first online registry for clinical trials and
remains widely used, not only for US-based trials. Its ori-
gins lie with the Health Omnibus Programs Extension Act
of 1988 (Public Law 100–607), which mandated the devel-
opment of a database of clinical trials of treatments for
AIDS. The registry was expanded under the Food and
Drug Modernization Act of 1997 (Public Act 105–115) [9].
The alternative to the US registry is the International
Standard Randomised Controlled Trial Number registry,
established in 1998. The UK register ISRCTN.org is a pri-
mary partner in the World Health Organisation platform,
run as Current Controlled Trials (CCT), part of Springer
Science+Business Media [9]. CCT provides free and open
access to information about registered randomised clinical
trials. From 2004 the UK Department of Health, under its
research governance framework, contracted with CCT to
register trials funded by the HTA programme and ‘those
funded at trust level by the NHS R&D Support Funding
stream’ [10]. ISRCTN numbers were allocated to all trials
funded by previous NHS R&D programmes, and to ‘own
account’ trials funded by NHS Trusts. CCT evidence to
the House of Commons noted that less than 5% of the
trials registered on the ISRCTN registry were funded by in-
dustry [10]. Industry-funded drug trials register elsewhere.
From 2004 all new and ongoing trials involving a Clinical
Trial Authorisation from the Medicines and Healthcare
Products Regulatory Agency had to register with the Euro-
pean database, EudraCT, which is confined to drugs and is
confidential.
Owing to it being the first international register, some
UK trials registered with ClinGov before the ISRCTN
register was established in 1998. The US register allo-
cates unique eight-digit numbers with the prefix NCT,
while the ISRCTN registers allocate eight-digit identi-
fiers with the prefix ISRCTN. Both the US and UK regis-
ters require largely the same data but with two key
differences: source of funding is a separate obligatory
field in ISRCTN but not in ClinGov. The other differ-
ence is that ClinGov provides free registration while
ISRCTN requires a registration fee (£200 in 2012). This
fee is met by the UK Department of Health for trials
funded by it or partner agencies but not for other trials.
The CCT website provides online access to both the
ClinGov and ISRCTN registers via a meta-register.ClinGov had 62,734 trials registered in November 2011
and ISRCTN had 10,153. We used the meta-register to
identify UK trials (defined to include all trials with at
least one recruitment centre in the UK) by register, to
estimate the total number of noncommercial trials over
time, and as far as possible to subdivide these trials by
funder type.
Our aim was to establish the number of UK-based
noncommercial randomised clinical trials registered each
year, with cross-checks against other sources, specifically
Chalmers data for 1990 to 2002 [4] and the UKCRN
portfolio database for 2007 to 2009 [5].
Methods
We compiled a dataset of noncommercial randomised
clinical trials due to start in the UK in any year between
1990 and 2009 from two trial registration databases, the
ISRCTN register [11] and the US register ClinicalTrials-
Gov [9]. Data were purchased from CCT on the trials in
the ISRCTN database, via a Wessex Institute small re-
search grant. Data on randomised clinical trials with at
least one UK centre registered with ClinGov were down-
loaded from the website with noncommercial trials iden-
tified using sponsors. Data were available from 1990 in
both databases due to the forerunner of ClinGov having
been established in 1988 and due to data on clinical
trials from the National Research Register [12], a prior
database of all Department of Health-funded research
projects, having been backloaded onto ISRCTN. This
enables comparison with Chalmers and colleagues’
results, whose survey covered trials commencing each
year from 1990 to 2003 [4].
Criteria for eligibility were description as a randomised
trial, a start date, a sponsor and, if available, a funder.
Duplicates were excluded and the records sorted by year
of proposed start of recruitment. Data extraction was
carried out by EF, LDo, AP and LDe. Classification of
funders was carried out independently by this group and
by JR, and differences were reconciled through further
web searches and discussion. The number of trials iden-
tified was compared with Chalmers and colleagues’ 2003
survey [4] and with the UKCRN portfolio database for
2007 to 2009 [5].
Results and discussion
A total of 4,569 eligible records were identified as eli-
gible after exclusion of duplicates.
The number of noncommercial trials registered
rose from 25 in 1990 to 188 in 1999, and to a peak
of 533 in 2002, before falling back to 334 in 2009
(Table 1). Figure 1 shows that the total number of
trials registered was similar to but slightly above
those in Chalmers and colleagues’ survey of funders
for first part of the period (up to 1998), but above
Table 1 Number of UK noncommercial trials registered
and distribution by ClinGov and ISRCTN, 1990 to 2009






1990 25 4 96
1991 10 0 100
1992 21 25 75
1993 42 16.7 83.2
1994 57 7.6 92.4
1995 132 7.6 92.4
1996 88 6.9 93.1
1997 132 8.3 91.7
1998 151 15.1 84.9
1999 188 8.5 91.5
2000 236 5.5 94.5
2001 265 13.6 86.4
2002 447 3.6 96.4
2003 533 8.3 91.7
2004 430 9.3 90.7
2005 458 13.5 86.5
2006 434 15.7 84.3
2007 291 31.3 68.7
2008 284 31.7 68.3
2009 334 35 65
Total 4,568
ClinGov, US Clinical Trials Government Register; ISRCTN, International Standard
Randomised Controlled Trial Number.
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2007 to 2009, the number registered to start each year
was similar to but slightly above the UKCRN database.Figure 1 Noncommercial trials registered, by year, with numbers in 2Table 1 shows where these trials registered. Less than
10% of UK trials registered with ClinGov for most years
before 2005 but the proportion rose thereafter to reach
35% by 2009.
The source of funding is shown in Table 2. Since
ClinGov does not include a field for sources of funding,
the funding for trials so registered was classed as unknown.
Owing to the increase in the proportion of UK trials regis-
tering with ClinGov, unknown funding accounted for the
largest share – 35% in 2009.
Charity includes Cancer Research UK and a small num-
ber of educational grants from pharmaceutical companies.
Other includes a small number of investigator-funded
projects and PhD studies. National Health Service (NHS)
R&D includes all NHS-funded projects with the excep-
tion of those randomised controlled trials with funder
indicated as an NHS Trust. Unknown indicates that ei-
ther the funding field was missing (almost all instances)
or had not been completed (rare). MRC, Medical Re-
search Council.
The sharp rise in the number of registered trials from
1999 to 2003 was due almost entirely to those registered
as funded by NHS Trusts (Figure 2). The proportion so
registered jumped from 17% in 1999 to 72% in 2003 be-
fore falling back to 18% in 2007. By 2009 the National In-
stitute for Health Research (NIHR), formerly NHS R&D,
was the largest funder (25%), followed by the charities
(17%), of which Cancer Research UK was the largest fol-
lowed by the Arthritis Research Council, the British Heart
Foundation and the Wellcome Trust.
The total number of UK noncommercial trials regis-
tered was similar to those of Chalmers and colleagues
for 1993 to 1998 [4] and to the UKCRN portfolio data-
base for 2007 to 2009 [5]. Between 1998 and 2002, the
second period of overlap with Chalmers and colleagues,003 survery and UK CRN portfolio.
Table 2 Noncommercial randomised UK clinical trials,
number registered each year by funder, 1990 to 2009
Funder Charity MRC NHS R&D NHS Trusts Other Unknown Total
1990 14 7 3 1 25
1991 3 6 1 10
1992 3 5 8 5 21
1993 7 10 15 3 7 42
1994 7 16 36 3 5 67
1995 22 13 76 10 1 10 132
1996 8 17 57 6 88
1997 16 18 78 8 1 11 132
1998 23 19 70 16 1 22 151
1999 15 38 85 33 1 16 188
2000 41 24 73 84 2 13 237
2001 41 12 39 134 2 37 265
2002 56 13 27 329 6 16 447
2003 54 10 32 388 5 44 533
2004 63 11 38 269 8 41 430
2005 77 15 40 252 11 63 458
2006 85 15 30 222 11 71 434
2007 75 16 47 55 7 91 291
2008 69 12 64 36 12 91 284
2009 59 15 89 45 8 118 334
Grand total 738 292 904 1,891 76 668 4,569
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colleagues’ survey fell.
The number of noncommercial trials registered over the
past 20 years has increased from under 200 before 2000 to
around 300 per annum from 2007 to 2009. A rapid rise in
the total from 1996 to a peak in 2003 of over 500 and the
subsequent fall to 2007 was evident. This was due mainly
to trials registered as funded in ISRCTN by NHS Trusts,
which have not previously been identified as major fun-
ders. No new funding became available to NHS Trusts
around this time. Governance of trials increased after the
EU Directive of 1999, which became UK law in 2004 with
the Medicines for Human Use (Clinical Trials) Regulations
[11]. The strong encouragement of trial registration around
that time in the UK may explain the rise in the number of
trials registered.
The decline in the number of trials registered as
funded by NHS Trusts after 2003 might be linked to
changes in funding. Each hospital had a largely notional
self-declared research fund that had historically covered
a range of activities, including the Service Increment for
Teaching and Research, Special Health Authorities,
‘tasked’ monies for general practice research and ‘own
account’ research [13-15]. In 2006/07 some £500 million
or some 80% of the NIHR (NHS R&D up to 2006)budget was hospital based [16]. These funds were succes-
sively known as Culyer Budget 1, infrastructure support,
Priorities and Needs Funding, and Support for Science
[17]. Some of what was termed ‘own account’ research
was funded by these funds. These considerable funds
were withdrawn over three transition years from 2006/07,
reducing the scope for NHS Trusts to fund research [18].
The decline in the number of trials registered as funded
by NHS Trusts from 2007 is plausibly linked to this
change in funding.
The rise in the proportion of UK trials registering with
ClinGov rather than ISRCTN is notable. This rose from
10 to 15% before 2007 to over 30% from 2007 to 2009.
Although the ISRCTN charges for registration, these
charges are met by the Department for Health for trials
funded by the main funders, specifically the NIHR, Medical
Research Council and the charities. It seems likely that
those trials registering with ClinGov were from other fun-
ders, such as ‘own account’ trials in trusts. Whatever the
reason, the rise in the use of ClinGov was unfortunate be-
cause of its lack of a field on the funding of the trial. This
means that in 2009 the largest group of trials were those
with unknown funding. If registration data are to be of use
in monitoring trends in noncommercial trials the source of
funding must be known.
Conclusions
Overall, for the periods of overlap with other sources, trial
registration data provide fairly similar results, except after
1998 when a rapid rise and fall in the number of trials
registered as funded by NHS Trusts occurred. We have
suggested that these changes may have been due to ‘own
account’ trials, with changes in governance leading to a rise
in registration and changes in funding accounting for the
fall. How many of the trials registered as funded by NHS
Trusts report their results remains to be seen.
As the number of trials registered as funded by NHS
Trusts has fallen, the number of UK randomised trials
registering with ClinGov has increased sharply, so that
35% of UK trials registering in 2009 were with ClinGov.
These were probably largely those trials previously regis-
tered as funded by NHS Trusts, but this cannot be
established without more detailed investigation.
Leaving aside trials registered as funded by NHS
Trusts, the overall trend has been upward since around
2002. By 2009 the two main funders were the NIHR and
charities. The role of the Medical Research Council,
already reduced, seems likely to shrink as NHS trials be-
come the responsibility of the NIHR. Owing to the
increased use of ClinGov by 2009, however, the largest
group of trials registered in that year had no data on the
funder. Further work to understand how these trials are
being funded and registered with ClinGov seems an ob-
vious priority.
Figure 2 Number of UK noncommercial randomised trials registered by funding source, 1990 to 2009.
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the number of noncommercial trials is complicated by
the use of two registers, and difficulties in accessing the
data. However, it is feasible to compile these data. We
recommend annual reporting on the total number of
noncommercial trials registering each year.
Finally, we acknowledge that the number of rando-
mised trials says nothing about the quality or size of
such trials. One good or large trial may be more valuable
than several poor or much smaller trials. Assessing the
quality and size of trials, however, are topics for further
study.
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